Plain-English translation of NCT06704672 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Accu-Chek SmartGuide CGM Solution, a wearable device that continuously monitors your blood sugar throughout the day and night. Researchers want to see whether using this device helps people with type 1 or type 2 diabetes spend more time with their blood sugar in a healthy range (70–180 mg/dL) compared to checking blood sugar the traditional way with a finger-stick meter. The study will compare how well the two approaches work over time.
Many people with diabetes struggle to keep their blood sugar in a healthy range using traditional testing methods, which only give a snapshot at the moment of testing. This study exists to find out whether continuous monitoring with this new device can help people better manage their diabetes and reduce the time they spend with dangerously high or low blood sugar.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either use the new continuous glucose monitor or continue with your current finger-stick testing method. You'll wear a small sensor patch on your skin (if in the monitor group) that measures your blood sugar automatically throughout the day. The study involves visits to the research clinic where your blood sugar control will be checked, and you'll be asked to keep track of how you're doing. The goal is to see which method helps you keep your blood sugar in a healthy range more of the time.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Poland